Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
Background: Doxorubicin is a widely used agent in the treatment of cancer, but the cardiotoxicity associated with this drug limits its potential for use. The cardioprotective effects of dapagliflozin, an antidiabetic drug, have the potential to counteract the cardiotoxic effect of doxorubicin therap...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
KARE Publishing
2023-05-01
|
| Serija: | Anatolian Journal of Cardiology |
| Teme: | |
| Online dostop: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-42888 |
| Oznake: |
Brez oznak, prvi označite!
|